Internal Medicine, Hematology & Oncology · Atlanta, GA
NPI
1386888220
Since 2009
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1364 Clifton Rd NE
Atlanta, GA, 30322
Phone (914) 318-9363
Groups this clinician bills Medicare through
Medicare paid, 2024
$14K
181 services
Medicare patients, 2024
123
Average age 73
Drug cost, 2024
$2.9M
811 prescriptions
Company payments, 2025
$22K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Conor E Steuer was code 99214 (office e&m - established), 35 times for 28 patients. In total Conor E Steuer billed 181 services in 13 codes, and Medicare paid $14K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-10-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 35 | 28 | $71.95 | $2,518 |
| 99214 Office E&M - Established | Office | 28 | 20 | $72.73 | $2,036 |
| 99204 Office E&M - New | Facility | 27 | 27 | $98.02 | $2,647 |
| 99213 Office E&M - Established | Office | 24 | 20 | $46.57 | $1,118 |
| 99204 Office E&M - New | Office | 22 | 22 | $102.72 | $2,260 |
| 99213 Office E&M - Established | Facility | 19 | 17 | $50.37 | $957 |
By year: 2022 $17K for 229 services; 2023 $16K for 215 services; 2024 $14K for 181 services.
Medicare prescription drug claims, 2024
In 2024, the drug Conor E Steuer prescribed most often to Medicare patients was Dexamethasone, with 140 prescriptions and refills. In total Conor E Steuer wrote 811 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dexamethasone Generic | 140 | 140 | 57 | $620 |
| Prochlorperazine Maleate Generic | 98 | 98 | 58 | $549 |
| Ondansetron Hcl Generic | 93 | 95 | 52 | $591 |
| Oxycodone Hcl Generic | 81 | 81 | 32 | $801 |
| Tagrisso Osimertinib Mesylate | 74 | 74 | 11 | $1.2M |
| Eliquis Apixaban | 34 | 38 | Under 11 | $22K |
| Mekinist Trametinib Dimethyl Sulfoxide | 28 | 28 | Under 11 | $429K |
| Tafinlar Dabrafenib Mesylate | 28 | 29 | Under 11 | $385K |
| Erlotinib Hcl Generic | 26 | 26 | Under 11 | $6,608 |
| Lorbrena Lorlatinib | 18 | 18 | Under 11 | $368K |
| Xarelto Rivaroxaban | 11 | 15 | Under 11 | $8,444 |
| Lidocaine Hcl Viscous Lidocaine Hcl | 11 | 11 | Under 11 | $208 |
| Ondansetron Odt Ondansetron | 11 | 11 | Under 11 | $95.8 |
| Alecensa Alectinib Hcl | 11 | 11 | Under 11 | $168K |
| Lenvima Lenvatinib Mesylate | 11 | 11 | Under 11 | $248K |
Brand drugs: 243 claims; generic drugs: 568 claims; opioid claims: 100.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Conor E Steuer $22K ($22K in general payments such as food, travel and fees) from 12 companies. The largest payer was Regeneron Pharmaceuticals, Inc. with $7,479.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.